Medium materiality6/10
BioMarin price target raised to $86 from $85 at Cantor Fitzgerald
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald raises BioMarin target to $86; current price $65.31; upside ~32%.
- Cantor Fitzgerald raises BioMarin target to $86; current $65.31; upside ~32%
Key facts
- 01
Target: $86
- 02
Posted price: $65.31
- 03
Analyst firm: Cantor Fitzgerald
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.